BGM Group Ltd. (BGM) vs Clever Leaves Holdings Inc. (CLVR)

BGM Group Ltd. and Clever Leaves Holdings Inc. are both Drug Manufacturers Specialty & Generic companies. BGM Group Ltd. is the larger, with a market value of $114.7M against $96.5M — 1.2× the size. Clever Leaves Holdings Inc. has negative trailing earnings, so its P/E is not meaningful; BGM Group Ltd. trades at 144×. BGM Group Ltd. has the higher net margin (1.96% vs −102.8%) and the higher return on invested capital (0.00% vs −52.6%). Across the 14 metrics below, BGM Group Ltd. leads on 9 and Clever Leaves Holdings Inc. on 5.

Valuation

Metric BGM CLVR Drug Manufacturers Specialty & Generic median
P/E 144.17 n/m 19.25
P/S n/m 0.00 2.11
P/B n/m 0.00 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m 0.44 12.58
EV/Sales (0.09) (0.33) 2.73
Earnings yield 0.69% (113,051.00%) (4.38%)
Free cash flow yield 0.00% (55,338.01%) 0.00%

Profitability

Metric BGM CLVR Drug Manufacturers Specialty & Generic median
Gross margin 6.54% 37.64% 53.94%
Operating margin 0.00% (89.53%) 0.00%
Net margin 1.96% (102.77%) 0.00%
Free cash flow margin 0.00% (49.82%) 0.00%
Return on equity 0.00% (55.39%) (0.40%)
Return on assets 0.00% (42.95%) (3.32%)
Return on invested capital 0.00% (52.59%) 0.00%

Growth

Metric BGM CLVR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 6.14% 10.01%
EPS growth (last fiscal year) 10.00% 77.89% 49.06%
Revenue growth, 5-year CAGR (5.39%) — 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGM CLVR Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.05 0.05
Current ratio 1.25 2.40 2.31
Net debt to EBITDA 0.97 0.45 0.97

Dividend

Metric BGM CLVR Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric BGM CLVR Drug Manufacturers Specialty & Generic median
Market cap 114.71m 96.49m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack